5,697
Views
15
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological & Psychiatric Disorders - Original Research

Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder

, , , &
Pages 461-472 | Received 02 May 2019, Accepted 19 Jul 2019, Published online: 01 Aug 2019

References

  • Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723.
  • Bernardi S, Faraone SV, Cortese S, et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012;42(4):875–887.
  • Biederman J, Petty C, Fried R, et al. Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(10):1730–1738.
  • Halmoy A, Fasmer OB, Gillberg C, et al. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13:175–187.
  • Kuriyan AB, Pelham WE Jr., Molina BS, et al. Young adult educational and vocational outcomes of children diagnosed with ADHD. J Abnorm Child Psychol. 2013;41(1):27–41.
  • Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007;190(5):402–409.
  • Gibbins C, Weiss M. Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults. Curr Psychiatry Rep. 2007;9:420–426.
  • Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med. 2008;120(3):27–38.
  • Jain R, Jain S, Montano CB. Addressing diagnosis and treatment gaps in adults with attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2017;19(5). [ Epub].
  • Wolraich M, Brown L, Brown, RT, et al.; Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022.
  • Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD practice guidelines. 3rd ed. Toronto, ON, Canada: CADDRA; 2011.
  • Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed. 2010;95(1):24–27.
  • Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  • Adler L, Shaw D, Sitt D, et al. Issues in the diagnosis and treatment of adult ADHD by primary care physicians. Prim Psychiatry. 2009;16(5):57–63.
  • Thomas M, Rostain A, Corso R, et al. ADHD in the college setting: current perceptions and future vision. J Atten Disord. 2014;19(8):643–654.
  • Klassen LJ, Blackwood CM, Reaume CJ, et al. A survey of adult referrals to specialist attention-deficit/hyperactivity disorder clinics in Canada. Int J Gen Med. 2018;11:1–10.
  • Al-Ahmari AA, Bharti RK, Al-Shahrani MS, et al. Knowledge, attitude, and performance of primary healthcare physicians in Aseer region, Saudi Arabia about attention deficit hyperactivity disorder. J Family Community Med. 2018;25(3):194–198.
  • Aksoy UM, Baysal ÖD, Aksoy ŞG, et al. Attitudes of psychiatrists towards the diagnosis and treatment of attention deficit and hyperactivity disorder in adults: a survey from Turkey. Nobel Medicus. 2015;11(3):28–32.
  • Ross WJ, Chan E, Harris SK, et al. Pediatrician-psychiatrist collaboration to care for children with attention deficit hyperactivity disorder, depression, and anxiety. Clin Pediatr (Phila). 2011;50(1):37–43.
  • McCarthy S, Wilton L, Murray M, et al. Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners. Health Qual Life Outcomes. 2013;11:22.
  • Ginsberg Y, Quintero J, Anand E, et al. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion CNS Disord. 2014;16(3):e1–e8.
  • Jerome L. Adult attention-deficit hyperactivity disorder is hard to diagnose and is undertreated. Can J Psychiatry. 2016;61(1):59.
  • Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35:245–256.
  • Ustun B, Adler LA, Rudin C, et al. The World Health Organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiatry. 2017;74(5):520–526.
  • Adler LA, Spencer TJ, Biederman J, et al. The internal consistency and validity of the Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trial. J ADHD Relat Disord. 2009;1(1):14–24.
  • Faraone SV, Silverstein MJ, Antshel K, et al. The adult ADHD quality measures initiative. J Atten Disord. 2019;23(10):1063–1078.
  • Ginsberg LD. Physicians’ impressions in once-daily treatment of patients diagnosed with attention-deficit/hyperactivity disorder: a survey on treatment efficacy and duration [poster]. Paper presented at: U.S. Psychiatric and Mental Health Congress; 2008 October 30–November 2; San Diego, CA.
  • Brown TE, Flood E, Sarocco P, et al. Persisting psychosocial impairments in adults being treated with medication for attention deficit/hyperactivity disorder [poster]. Paper presented at: American Psychiatric Association; 2017 May 20–24; San Diego, CA.
  • Goodman DW, Surman CB, Scherer PB, et al. Assessment of physician practices in adult attention-deficit/hyperactivity disorder. Prim Care Companion CNS Disord. 2012;14(4). pii: PCC.11m01312. DOI: 10.4088/PCC.11m01312. [ Epub].
  • Bushe C, Wilson B, Televantou F, et al. Understanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database study. Pragmat Obs Res. 2015;6:1–12.
  • McCarthy S, Wilton L, Murray ML, et al. Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry. 2012;12:219.
  • Waite R, Vlam RC, Irrera-Newcomb M, et al. The diagnosis less traveled: NPs’ role in recognizing adult ADHD. J Am Assoc Nurse Pract. 2013;25(6):302–308.
  • Mao AR, Findling RL. Comorbidities in adult attention-deficit/hyperactivity disorder: a practical guide to diagnosis in primary care. Postgrad Med. 2014;126(5):42–51.
  • Kooij JJ, Huss M, Asherson P, et al. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012;16(5suppl):3S–19S.
  • Meyers J, Grebla R, Ajmera M, et al. Comorbidity burden in delayed and nondelayed ADHD diagnosis among commercially insured adults in the United States [poster]. Paper presented at: US Psychiatric and Mental Health Congress; 2015 September 10–13; San Diego, CA.
  • Bolea-Alamanac B, Nutt DJ, Adamou M, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(3):179–203.
  • Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71:754–763.
  • Karlstad O, Zoega H, Furu K, et al. Use of drugs for ADHD among adults–a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol. 2016;72(12):1507–1514.
  • Zhou Z, Zhou ZY, Kelkar SS, et al. Medication use in adults with attention deficit/hyperactivity disorder in a commercially-insured population in the United States. Curr Med Res Opin. 2018;34(4):585–592.
  • Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31.
  • Sepulveda DR, Thomas LM, McCabe SE, et al. Misuse of prescribed stimulant medication for ADHD and associated patterns of substance use: preliminary analysis among college students. J Pharm Pract. 2011;24(6):551–560.